ストックスクリーナーアプリを入手
33.64
0.65%
-0.22
アフターアワーズ：
33.70
0.06
+0.18%
前日終値:
$33.86
開ける：
$33.8
24時間の取引高:
2.24M
Relative Volume:
0.78
時価総額：
$6.90B
収益：
$264.79M
当期純損益:
$-14.36M
株価収益率:
-305.82
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
-22.56%
1か月 パフォーマンス:
-6.16%
6か月 パフォーマンス:
+16.77%
1年 パフォーマンス:
+98.82%
1日の値動き範囲:
$33.45
$34.73
1週間の範囲:
$33.15
$40.48
52週間の値動き範囲:
$15.16
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
33.64 | 6.90B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TG Therapeutics stock sinks on profit miss - MSN
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook By Stocktwits - Investing.com India
TG Therapeutics: Q1 Earnings Snapshot - MySA
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga
Why TG Therapeutics Stock Was Tumbling Today - AOL.com
TGTX Stock Dips Despite Surging Revenue and Profitability - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target - Investing.com
TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX) - Seeking Alpha
TG Therapeutics (TGTX) Stock Falls After Earnings Miss Despite Raised Guidance - GuruFocus
TG Therapeutics stock sinks on profit miss (TGTX:NASDAQ) - Seeking Alpha
Strong Q1 Performance for TG Therapeutics (TGTX) with BRIUMVI Growth - GuruFocus
Earnings call transcript: TG Therapeutics misses Q1 2025 EPS forecast, shares dip - Investing.com
TG Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic - MSN
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - Yahoo Finance
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire
TG Therapeutics (TGTX) Misses Q1 EPS Estimates, Raises 2025 Revenue Projections - GuruFocus
TG Therapeutics Inc (TGTX) Reports Q1 2025 Revenue of $119.7 Million, Surpassing Estimates - GuruFocus
TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated - marketscreener.com
TG Therapeutics Reports First Quarter 2025 Financial Results - TradingView
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance | TGTX Stock News - GuruFocus
TG Therapeutics Q1 revenue beats estimates, stock edges higher By Investing.com - Investing.com Canada
TG Therapeutics Q1 revenue beats estimates, stock edges higher - Investing.com
TGTX Surpasses Revenue Expectations with Strong Q1 Performance | TGTX Stock News - GuruFocus
Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.03, vs. FactSet Est of $0.17 - marketscreener.com
Earnings Flash (TGTX) TG Therapeutics Reports Q1 Revenue $120.9M, vs. FactSet Est of $117.9M - marketscreener.com
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire Inc.
TG Therapeutics Earnings Loom With Stock (NASDAQ: TGTX) Outperforming Market - AskTraders.com
When (TGTX) Moves Investors should Listen - news.stocktradersdaily.com
TG Therapeutics (TGTX) Schedules Q1 2025 Earnings Call - GuruFocus
TG Therapeutics (TGTX) Poised for Major Earnings Growth in Q1 - GuruFocus
TG Therapeutics stock soars to 52-week high of $45.28 By Investing.com - Investing.com India
TG Therapeutics stock soars to 52-week high of $45.28 - Investing.com
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
TG Therapeutics to Host Conference Call on First Quarter 2025 Fi - GuruFocus
TG Therapeutics to Host Conference Call on May 5, 2025, to Discuss Q1 Financial Results and 2025 Outlook - Nasdaq
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update - GlobeNewswire
Investor Network: TG Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm - ACCESS Newswire
TG Therapeutics (NasdaqCM:TGTX) Sees Profitable Turn With Strong Quarterly Earnings - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
TG Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):